China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds ...

The biotech sector has underperformed the overall market. Those are sentiments echoed by JPMorgan analyst Chris Schott, given ...

Verve Therapeutics stock jumped after a report said pharmaceutical giant Eli Lilly is in advanced talks to buy the ...

However, RBC Capital has reiterated that Vertex could require stronger execution to adopt Alyftrek to justify the current ...

In the volatile biotech industry, it is easy to overlook small-cap medical device companies, particularly those that are not ...

China's biotechnology stocks have experienced a significant rally, outperforming AI, with a 60% surge since January due to ...

Biotech stock Verve Therapeutics Inc (NASDAQ:VERV) is up 75.3% to trade at $10.99 at last check amid news that peer Eli Lilly ...

Fact checked by Vikki Velasquez More people need better medicines, and there is a rising demand for food and sustainable ...

The rally in the sector this year outpaces the 17% gain in China’s tech stocks that was driven by the release of DeepSeek’s ...

Parataxis is launching a Bitcoin treasury platform for South Korean institutional investors, which saw Bridge Bio’s stock ...

Crinetics Pharmaceuticals trades at a steep discount while maintaining strong analyst support and a ~$3B valuation. Learn why ...

Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable ...